Activated Vγ9Vδ2 T Cells Trigger Granulocyte Functions via MCP-2 Release

被引:35
作者
Agrati, Chiara [1 ]
Cimini, Eleonora [1 ]
Sacchi, Alessandra [1 ]
Bordoni, Veronica [1 ]
Gioia, Cristiana [1 ]
Casetti, Rita [1 ]
Turchi, Federica [1 ]
Tripodi, Marco [1 ]
Martini, Federico [1 ]
机构
[1] Natl Inst Infect Dis Lazzaro Spallanzani, IRCCS, Rome, Italy
关键词
NONPEPTIDE ANTIGENS; MYCOBACTERIUM-TUBERCULOSIS; ANTIVIRAL IMMUNITY; ZOLEDRONIC ACID; CC CHEMOKINES; IN-VITRO; INFECTION; DEFENSINS; STIMULATION; LYMPHOCYTES;
D O I
10.4049/jimmunol.182.1.522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2 T cells display a broad antimicrobial activity by directly killing infected cells and by inducing an effective adaptive immune response. The activation of V gamma 9V delta 2 T cells by aminobisphosphonate drugs such as zoledronic acid (ZOL) results in a massive release of cytokines and chemokines that may induce a bystander activation of other immune cells. The aim of this work was to evaluate the ability of soluble factors released by ZOL-activated V gamma 9V delta 2 T cells to induce granulocyte activation. We showed that soluble factors released by ZOL-stimulated V gamma 9V delta 2 T cells activate granulocytes by inducing their chemotaxis, phagocytosis, and alpha-defensins release. Proteomic analysis allowed us to identify a number of cytokines and chemokines specifically released by activated V gamma 9V delta 2 T cells. Moreover, MCP-2 depletion by neutralizing Ab revealed a critical role of this chemokine in induction of granulocyte alpha-defensins release. Altogether, these data show a V gamma 9V delta 2-mediated activation of granulocytes through a bystander mechanism, and confirm the wide ability of V gamma 9V delta 2 T-lymphocytes in orchestrating the immune response. In conclusion, an immune modulating strategy targeting V gamma 9V delta 2 T cells may represent a key switch to induce an effective and well-coordinated immune response, and can be proposed as a way to strengthen the immune competence during infectious diseases. The Journal of Immunology, 2009, 182: 522-529.
引用
收藏
页码:522 / 529
页数:8
相关论文
共 50 条
  • [41] Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid
    Inoue, Yusuke
    Oda, Asuka
    Maeda, Yusaku
    Sumitani, Ryohei
    Oura, Masahiro
    Sogabe, Kimiko
    Maruhashi, Tomoko
    Takahashi, Mamiko
    Fujii, Shiro
    Nakamura, Shingen
    Miki, Hirokazu
    Hiasa, Masahiro
    Teramachi, Jumpei
    Harada, Takeshi
    Abe, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 626 - 630
  • [42] TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells
    Papadopoulou, Maria
    Tieppo, Paola
    McGovern, Naomi
    Gosselin, Francoise
    Chan, Jerry K. Y.
    Goetgeluk, Glenn
    Dauby, Nicolas
    Cogan, Alexandra
    Donner, Catherine
    Ginhoux, Florent
    Vandekerckhove, Bart
    Vermijlen, David
    JOURNAL OF IMMUNOLOGY, 2019, 203 (06) : 1468 - 1479
  • [43] Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
    Gruenbacher, Georg
    Nussbaumer, Oliver
    Gander, Hubert
    Steiner, Bernhard
    Leonhartsberger, Nicolai
    Thurnher, Martin
    ONCOIMMUNOLOGY, 2014, 3 (08): : 1 - 12
  • [44] Reduced Expression of the Mevalonate Pathway Enzyme Farnesyl Pyrophosphate Synthase Unveils Recognition of Tumor Cells by Vγ9Vδ2 T Cells
    Li, Jianqiang
    Herold, Marco J.
    Kimmel, Brigitte
    Mueller, Ingrid
    Rincon-Orozco, Bladimiro
    Kunzmann, Volker
    Herrmann, Thomas
    JOURNAL OF IMMUNOLOGY, 2009, 182 (12) : 8118 - 8124
  • [45] Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells
    Poccia, Fabrizio
    Gioia, Cristiana
    Martini, Federico
    Sacchi, Alessandra
    Piacentini, Paola
    Tempestilli, Massimo
    Agrati, Chiara
    Amendola, Alessandra
    Abdeddaim, Amina
    Vlassi, Chrysoula
    Malkovsky, Miroslav
    D'Offizi, Gianpiero
    AIDS, 2009, 23 (05) : 555 - 565
  • [46] Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2T Cells
    Dunne, Margaret R.
    Mangan, Bozgana A.
    Madrigal-Estebas, Laura
    Doherty, Derek G.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [47] F1-Adenosine Triphosphatase Displays Properties Characteristic of an Antigen Presentation Molecule for Vγ9Vδ2 T Cells
    Mookerjee-Basu, Jayati
    Vantourout, Pierre
    Martinez, Laurent O.
    Perret, Bertrand
    Collet, Xavier
    Perigaud, Christian
    Peyrottes, Suzanne
    Champagne, Eric
    JOURNAL OF IMMUNOLOGY, 2010, 184 (12) : 6920 - 6928
  • [48] Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma
    Goto, Hirold
    Matsuda, Kould
    Srikoon, Pattaravadee
    Kariya, Ryusho
    Hattori, Shinichiro
    Taura, Manabu
    Katano, Harutaka
    Okada, Seiji
    CANCER LETTERS, 2013, 331 (02) : 174 - 182
  • [49] Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo
    Santolaria, Thibault
    Robard, Myriam
    Leger, Alexandra
    Catros, Veronique
    Bonneville, Marc
    Scotet, Emmanuel
    JOURNAL OF IMMUNOLOGY, 2013, 191 (04) : 1993 - 2000
  • [50] TCR repertoire analysis reveals phosphoantigen-induced polyclonal proliferation of Vγ9Vδ2 T cells in neonates and adults
    Fichtner, Alina S.
    Bubke, Anja
    Rampoldi, Francesca
    Wilharm, Anneke
    Tan, Likai
    Steinbrueck, Lars
    Schultze-Florey, Christian
    Von Kaisenberg, Constantin
    Prinz, Immo
    Herrmann, Thomas
    Ravens, Sarina
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (06) : 1023 - 1032